Outpost Bio Raises $3.5M Pre-Seed

Outpost Bio is developing AI models focused on human microbiology to decode how microbial communities within the body interact with drugs and nutrients. The company's "Lab-in-the-Loop" platform combines automated wet lab experiments with machine learning in a continuous feedback cycle to generate proprietary data. This approach aims to help pharmaceutical and consumer goods companies design safer and more effective products. The funding round was co-led by two distinct European VCs. Merantix Capital is a Berlin-based firm that specializes in early-stage applied AI companies, with a particular focus on tech-bio and healthcare automation. Seedcamp, a London-based fund founded in 2007, has a notable portfolio that includes successes like Revolut and UiPath and provides founders with a platform for learning and networking. In Colombia, the U Ventures fund is a ~$12,000 million COP initiative created in partnership with Fundación Fraternidad Medellín, Universidad Eafit, and Universidad EIA. The fund's five-year goal is to incubate 300 university-based startups, providing direct investment to at least 30 of them through a 16-week program of training and mentorship. The U Ventures fund was launched to address a structural problem in Medellín's startup ecosystem. Despite the city being home to 25% of Colombia's startups, up to 90% of venture capital investment has historically come from foreign funds, creating a critical gap in local, early-stage support. The fund will target startups in sectors including life sciences, health, financial inclusion, sustainability, and creative industries. This initiative is part of a broader strategy to establish Medellín as a global hub for entrepreneurship and venture capital, supported by organizations like Ruta N. Meanwhile, the global increase in AI-related funding is particularly evident in the gaming industry. Investment in AI gaming startups surged from just 4% of the sector's infrastructure deals in 2020 to approximately 65% in 2024, signaling a major strategic shift among venture capitalists.